Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

Inducing Targeted Protein Degradation: From Chemical Biology to Drug Discovery and Clinical Applications

by Philipp Cromm
Save 14% Save 14%
Current price ₹13,929.00
Original price ₹16,250.00
Original price ₹16,250.00
Original price ₹16,250.00
(-14%)
₹13,929.00
Current price ₹13,929.00

Imported Edition - Ships in 18-21 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Hardcover
  • ISBN13: 9783527350131
  • Binding: Hardcover
  • Subject: N/A
  • Publisher: Wiley-Vch
  • Publisher Imprint: Wiley-Vch
  • Publication Date: N/A
  • Pages: 368
  • Original Price: GBP 125.0
  • Language: English
  • Edition: N/A
  • Item Weight: 880 grams
  • BISAC Subject(s): Pharmacology

Inducing Targeted Protein Degradation

Enables drug developers in academia and industry to expand the range of accessible drug targets through induced protein degradation

Since the breakthrough of the PROTAC technology in 2015, targeted protein degradation has revolutionized drug discovery, enabling pharma companies to develop completely novel therapeutics. Inducing Targeted Protein Degradation is a timely guide to navigating the complexities of the subject and understanding its practical application, with an eye on expanding the druggable space.

In Inducing Targeted Protein Degradation, readers will find the most recent information on:

  • Cellular mechanisms of targeted protein degradation and current approaches to utilize these mechanisms for drug discovery
  • A comparison of different induced degradation approaches, including PROTAC, molecular glues, LYTACs and ATTECs as well as additional post translational modifications
  • Drug development aspects such as DMPK optimization and criteria for the selection of clinical candidates
  • A discussion of the potential of targeted degradation for expanding the druggable space

Inducing Targeted Protein Degradation will serve as a practice-oriented reference on induced protein degradation for drug discovery professionals and for researchers employing chemical biology approaches.

Philipp Cromm studied Chemistry at the Technical University Munich where he worked in the group of Horst Kessler. For his master's thesis he spent time with David J. Craik at the Institute for Molecular Bioscience and received his PhD under guidance of Herbert Waldmann at the Max-Planck-Institute for Molecular Physiology. Thereafter, he carried out postdoctoral studies in the group of Craig Crews at Yale University working on targeted protein degradation. In 2018 Philipp joined Bayer AG as a Medicinal Chemist.

Trusted for over 49 years

Family Owned Company

Secure Payment

All Major Credit Cards/Debit Cards/UPI & More Accepted

New & Authentic Products

India's Largest Distributor

Need Support?

Whatsapp Us